Wave Life Sciences Q3 2023 EPS $0.07 Beats $(0.18) Estimate, Revenue $49.21M Beats $23.43M Estimate
Portfolio Pulse from Benzinga Newsdesk
Wave Life Sciences reported Q3 2023 earnings per share (EPS) of $0.07, beating the estimate of $(0.18). The company's revenue was $49.21M, surpassing the estimate of $23.43M.
November 09, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wave Life Sciences reported better than expected Q3 2023 results with EPS of $0.07 and revenue of $49.21M.
Wave Life Sciences reported Q3 2023 earnings that beat estimates. This is typically seen as a positive sign by investors and could lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100